Total Payments
$53,184
2023 Payments
$101.43
Companies
21
Transactions
169
Medicare Patients
1,562
Medicare Billing
$314,605
Payment Breakdown by Category
Other$43,145 (81.1%)
Travel$5,840 (11.0%)
Food & Beverage$4,178 (7.9%)
Education$20.65 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,945 | 17 | 78.9% |
| Travel and Lodging | $5,840 | 31 | 11.0% |
| Food and Beverage | $4,178 | 118 | 7.9% |
| Honoraria | $1,200 | 1 | 2.3% |
| Education | $20.65 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $28,599 | 33 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $22,813 | 75 | $0 (2019) |
| Allergan Inc. | $306.45 | 18 | $0 (2019) |
| GlaxoSmithKline, LLC. | $273.65 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $202.88 | 6 | $0 (2023) |
| Edwards Lifesciences Corporation | $183.95 | 1 | $0 (2020) |
| Genentech USA, Inc. | $164.37 | 2 | $0 (2019) |
| Grifols USA, LLC | $144.99 | 2 | $0 (2018) |
| Advanced Respiratory, Inc | $128.22 | 2 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $46.35 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.43 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($101.43) |
| 2022 | $25.55 | 1 | Actelion Pharmaceuticals US, Inc. ($25.55) |
| 2020 | $183.95 | 1 | Edwards Lifesciences Corporation ($183.95) |
| 2019 | $3,946 | 35 | Sunovion Pharmaceuticals Inc. ($3,304) |
| 2018 | $41,450 | 85 | La Jolla Pharmaceutical Company ($28,434) |
| 2017 | $7,477 | 46 | Sunovion Pharmaceuticals Inc. ($6,913) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $101.43 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Cardiology | ||||||
| 01/29/2020 | Edwards Lifesciences Corporation | EV1000 Clinical Platform (Device) | Food and Beverage | In-kind items and services | $183.95 | General |
| Category: Minimally Invasive Hemodynamic Monitoring | ||||||
| 09/27/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 07/09/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory and Allergy | ||||||
| 05/28/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,280.00 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Travel and Lodging | In-kind items and services | $252.42 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | Cash or cash equivalent | $71.52 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $56.40 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $50.41 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Travel and Lodging | Cash or cash equivalent | $24.70 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | Cash or cash equivalent | $4.11 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Travel and Lodging | In-kind items and services | $293.20 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Travel and Lodging | In-kind items and services | $185.92 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $139.43 | General |
| 03/26/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2019 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/13/2019 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $40.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 301 | 432 | $201,090 | $54,799 |
| 2022 | 4 | 358 | 545 | $255,030 | $68,931 |
| 2021 | 4 | 472 | 766 | $383,285 | $104,476 |
| 2020 | 4 | 431 | 620 | $307,745 | $86,399 |
Total Patients
1,562
Total Services
2,363
Medicare Billing
$314,605
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 114 | 162 | $107,730 | $27,582 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 103 | 178 | $53,400 | $17,257 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 50 | $29,250 | $7,110 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 30 | $6,750 | $1,793 | 26.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 11 | 12 | $3,960 | $1,058 | 26.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 154 | 222 | $147,630 | $39,333 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 128 | 247 | $74,100 | $20,478 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 45 | $26,325 | $7,311 | 27.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 31 | $6,975 | $1,810 | 25.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 218 | 400 | $266,000 | $71,675 | 26.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 168 | 273 | $81,900 | $23,308 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 42 | 42 | $24,570 | $6,543 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 51 | $10,815 | $2,950 | 27.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 210 | 325 | $216,125 | $59,665 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 148 | 213 | $63,900 | $18,791 | 29.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 28 | $16,380 | $4,629 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 45 | 54 | $11,340 | $3,314 | 29.2% |
About Dr. Peter Murphy, M.D
Dr. Peter Murphy, M.D is a Critical Care Medicine healthcare provider based in Carmichael, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437191657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Murphy, M.D has received a total of $53,184 in payments from pharmaceutical and medical device companies, with $101.43 received in 2023. These payments were reported across 169 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,945).
As a Medicare-enrolled provider, Murphy has provided services to 1,562 Medicare beneficiaries, totaling 2,363 services with total Medicare billing of $314,605. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Carmichael, CA
- Active Since 06/12/2006
- Last Updated 07/21/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1437191657
Products in Payments
- GIAPREZA (Drug) $28,434
- LONHALA MAGNAIR (Drug) $12,941
- UTIBRON (Drug) $9,781
- AVYCAZ (Drug) $280.12
- EV1000 Clinical Platform (Device) $183.95
- TRELEGY ELLIPTA (Drug) $166.35
- Prolastin-C (Biological) $144.99
- The Vest System Model 105 Home Care (Device) $128.22
- OFEV (Drug) $121.40
- Utibron (Drug) $77.41
- STIOLTO RESPIMAT (Drug) $67.59
- ANORO (Drug) $47.75
- Xerava (Drug) $44.69
- NUCALA (Biological) $36.89
- SYMBICORT (Drug) $33.50
- ENTRESTO (Drug) $29.38
- GLASSIA (Biological) $29.10
- XARELTO (Drug) $28.35
- Precision Flow (Device) $25.97
- UPTRAVI (Drug) $25.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.